Cargando…

Role of Epstein-Barr Virus in Pathogenesis and Racial Distribution of IgA Nephropathy

IgA nephropathy (IgAN) is the dominant type of primary glomerulonephritis worldwide. However, IgAN rarely affects African Blacks and is uncommon in African Americans. Polymeric IgA1 with galactose-deficient hinge-region glycans is recognized as auto-antigen by glycan-specific antibodies, leading to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zachova, Katerina, Kosztyu, Petr, Zadrazil, Josef, Matousovic, Karel, Vondrak, Karel, Hubacek, Petr, Julian, Bruce A., Moldoveanu, Zina, Novak, Zdenek, Kostovcikova, Klara, Raska, Milan, Mestecky, Jiri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058636/ https://www.ncbi.nlm.nih.gov/pubmed/32184780 http://dx.doi.org/10.3389/fimmu.2020.00267

Ejemplares similares

IgA Nephropathy: Pleiotropic impact of Epstein-Barr virus infection on immunopathogenesis and racial incidence of the disease
por: Mestecky, Jiri, et al.
Publicado: (2023)

GalNAc-T14 may Contribute to Production of Galactose-Deficient Immunoglobulin A1, the Main Autoantigen in IgA Nephropathy
por: Jemelkova, Jana, et al.
Publicado: (2023)

The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy
por: Knoppova, Barbora, et al.
Publicado: (2016)

Differential glycosylation of envelope gp120 is associated with differential recognition of HIV-1 by virus-specific antibodies and cell infection
por: Raska, Milan, et al.
Publicado: (2014)

Differential glycosylation of envelope gp120 affects reactivity with HIV-1 specific antibodies
por: Czernekova, Lydie, et al.
Publicado: (2014)

Enzymatic Sialylation of IgA1 O-Glycans: Implications for Studies of IgA Nephropathy
por: Takahashi, Kazuo, et al.
Publicado: (2014)

Glycosylation Patterns of HIV-1 gp120 Depend on the Type of Expressing Cells and Affect Antibody Recognition
por: Raska, Milan, et al.
Publicado: (2010)

Cytokines Alter IgA1 O-Glycosylation by Dysregulating C1GalT1 and ST6GalNAc-II Enzymes
por: Suzuki, Hitoshi, et al.
Publicado: (2014)

Autoantibodies Specific for Galactose-Deficient IgA1 in IgA Vasculitis With Nephritis
por: Suzuki, Hitoshi, et al.
Publicado: (2019)

Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy
por: Yamada, Koshi, et al.
Publicado: (2017)

Serial Galactose-Deficient IgA1 Levels in Children with IgA Nephropathy and Healthy Controls
por: Sanders, John T., et al.
Publicado: (2017)

Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
por: Suzuki, Hitoshi, et al.
Publicado: (2016)

The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression
por: Zhao, Na, et al.
Publicado: (2012)

Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection
por: Russell, Michael W., et al.
Publicado: (2020)

Serum Galactose-Deficient IgA1 Level Is Not Associated with Proteinuria in Children with IgA Nephropathy
por: Hastings, M. Colleen, et al.
Publicado: (2012)

Network Analysis for Uncovering the Relationship between Host Response and Clinical Factors to Virus Pathogen: Lessons from SARS-CoV-2
por: Sova, Milan, et al.
Publicado: (2022)

Association of IgG co-deposition with serum levels of galactose-deficient IgA1 in pediatric IgA nephropathy
por: Eison, T. Matthew, et al.
Publicado: (2012)

Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma.
por: Ho, H. C., et al.
Publicado: (1976)

IgA antibodies to Epstein-Barr viral capsid antigens in saliva of nasopharyngeal carcinoma patients.
por: Ho, H. C., et al.
Publicado: (1977)

Secretory IgA N-glycans contribute to the protection against E. coli O55 infection of germ-free piglets
por: Raskova Kafkova, Leona, et al.
Publicado: (2020)

Cellular Signaling and Production of Galactose-Deficient IgA1 in IgA Nephropathy, an Autoimmune Disease
por: Reily, Colin, et al.
Publicado: (2014)

Efficacy of Chemiluminescence Immunoassays on VCA-IgA and EBNA1-IgA Antibodies of Epstein-Barr Virus in Diagnosing Nasopharyngeal Carcinoma
por: Yu, Xia, et al.
Publicado: (2020)

Proteins mimicking epitope of HIV-1 virus neutralizing antibody induce virus-neutralizing sera in mice
por: Kosztyu, Petr, et al.
Publicado: (2019)

Factors affecting serum IgA antibody to Epstein-Barr viral capsid antigens in nasopharyngeal carcinoma.
por: Ho, H. C., et al.
Publicado: (1978)

Myomedin replicas of gp120 V3 loop glycan epitopes recognized by PGT121 and PGT126 antibodies as non-cognate antigens for stimulation of HIV-1 broadly neutralizing antibodies
por: Daniel Lišková, Veronika, et al.
Publicado: (2022)

The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)

Comparative Evaluation of HIV-1 Neutralization in External Secretions and Sera of HIV-1-Infected Women
por: Wei, Qing, et al.
Publicado: (2012)

Differences in serum IgA responses to HIV-1 gp41 in elite controllers compared to viral suppressors on highly active antiretroviral therapy
por: Nabi, Rafiq, et al.
Publicado: (2017)

Epstein - Barr virus Pneumonitis
por: McManus, Terence E, et al.
Publicado: (2009)

Epstein–Barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein–barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein-Barr virus and skin
por: Sangueza-Acosta, Martin, et al.
Publicado: (2018)

Epstein-Barr Virus Gastritis
por: Oki, Masayuki, et al.
Publicado: (2017)

Resurrecting Epstein–Barr Virus
por: Paganelli, Roberto
Publicado: (2022)

Targeting ERK-Hippo Interplay in Cancer Therapy
por: Vališ, Karel, et al.
Publicado: (2020)

Potential Cellular Functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus
por: Smith, Danielle Westhoff, et al.
Publicado: (2013)

Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
por: Wongwiwat, Wiyada, et al.
Publicado: (2022)

Racial heterogeneity of IgA1 hinge-region O-glycoforms in patients with IgA nephropathy
por: Ohyama, Yukako, et al.
Publicado: (2022)

Myomedin scaffold variants targeted to 10E8 HIV-1 broadly neutralizing antibody mimic gp41 epitope and elicit HIV-1 virus-neutralizing sera in mice
por: Kuchař, Milan, et al.
Publicado: (2021)

Epstein-Barr Virus and Human Cancer
por: Young, Lawrence
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_jo464p6lm42tge010vptqsam9r